Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience

International Journal of Impotence Research volume 17, pages 307–319 (2005)Cite this article

Abstract

The Sexual Health Inventory for Men (SHIM) is a widely used scale for screening and diagnosis of erectile dysfunction (ED) and severity of ED in clinical practice and research. In reviewing the SHIM-related literature, we sought to provide a compendium of studies in which the SHIM was used, to provide a systematic framework for organizing and evaluating the studies, and to provide a status report on the SHIM and its impact on the management of male sexual dysfunction. Using a Medline search, we found that the SHIM was an integral measure in at least 21 studies on the prevalence of ED, 23 studies on the efficacy of ED interventions, and eight other (mainly correlational) studies. The quantity of research and quality of scholarship on the SHIM provide testimony to its positive impact on understanding and improving male sexual function. These scientific contributions are likely to remain influential in coming years.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rosen RC et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.

    Article  CAS  Google Scholar 

  2. Rosen RC, Cappelleri JC, Gendrano N . The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14: 226–244.

    Article  CAS  Google Scholar 

  3. NIH Consensus Panel on Impotence. Impotence. JAMA 1993; 270: 83–90.

  4. Rosen RC et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

    Article  CAS  Google Scholar 

  5. Cappelleri JC et al. Relationship between patient self-assessment of erectile function and the Sexual Health Inventory for Men. Clin Ther 2001; 23: 1707–1719.

    Article  CAS  Google Scholar 

  6. Sánchez Merino JM et al. Prevalencia y factores de riesgo de disfunción eréctil en la Comarca del Bierzo. Arch Esp Urol 2001; 54: 229–239.

    PubMed  Google Scholar 

  7. Hakim J, Subit M, Kandzari S, Zaslau S . Quality control in the screening of erectile dysfunction—results of a survey. Urology 2002; 60: 125–129.

    Article  CAS  Google Scholar 

  8. Rhoden EL, Telöken C, Mafessoni R, Vargas Souto CA . Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction? Int J Impot Res 2002; 14: 167–171.

    Article  CAS  Google Scholar 

  9. Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA . The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002; 14: 245–250.

    Article  CAS  Google Scholar 

  10. Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA . The relationship of serum testosterone to erectile function in normal aging men. J Urol 2002; 167: 1745–1748.

    Article  CAS  Google Scholar 

  11. Cho BL et al. Prevalence and risk factors for erectile dysfunction in primary care: results of a Korean study. Int J Impot Res 2003; 15: 323–328.

    Article  CAS  Google Scholar 

  12. Sasayama S et al. Men's health study: current status of erectile dysfunction of 6,112 ambulatory patients at general practitioners offices in Japan. J Cardiol 2003; 42: 57–65.

    PubMed  Google Scholar 

  13. Giuliano F et al. Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 2002; 42: 382–389.

    Article  Google Scholar 

  14. Monga M, Bettencourt R, Barrett-Connor E . Community-based study of erectile dysfunction and sildenafil use: the Rancho Bernardo Study. Urology 2002; 59: 753–757.

    Article  Google Scholar 

  15. Tan JK et al. Erectile dysfunction in Singapore: prevalence and its associated factors—a population-based study. Singapore Med J 2003; 44: 20–26.

    CAS  PubMed  Google Scholar 

  16. Naya Y et al. Preliminary report of association of chronic diseases and erectile dysfunction in middle-aged men in Japan. Urology 2003; 62: 532–536.

    Article  Google Scholar 

  17. Liang C et al. Investigation and analysis of chronic prostatitis and sexual dysfunction. Zhonghua Nan Ke Xue 2004; 10: 434–436.

    PubMed  Google Scholar 

  18. Malavaud B et al. High prevalence of erectile dysfunction after renal transplantation. Transplantation 2000; 69: 2121–2124.

    Article  CAS  Google Scholar 

  19. Rebollo P et al. Factors associated with erectile dysfunction in male kidney transplant recipients. Int J Impot Res 2003; 15: 433–438.

    Article  CAS  Google Scholar 

  20. Rosas SE et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 2001; 59: 2259–2266.

    Article  CAS  Google Scholar 

  21. Krishnan R, Izatt S, Bargman JM, Oreopoulos D . Prevalence and determinants of erectile dysfunction in patients on peritoneal analysis. Int Urol Nephrol 2003; 35: 553–556.

    Article  Google Scholar 

  22. Rhoden EL et al. Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil. Int J Impot Res 2001; 13: 291–293.

    Article  CAS  Google Scholar 

  23. Cuéllar de León AJ et al. Prevalencia de disfunción eréctil en pacientes con hypertension arterial. Med Clin 2002; 119: 521–526.

    Article  Google Scholar 

  24. Naya Y et al. Erythrocyte aldose reductase correlates with erectile dysfunction in diabetic patients. Int J Impot Res 2002; 14: 213–216.

    Article  CAS  Google Scholar 

  25. Kloner RA et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol 2003; 170: S46–S50.

    Article  Google Scholar 

  26. Hong P et al. Erectile dysfunction associated with scleroderma: a case–control study of men with scleroderma and rheumatoid arthritis. J Rheumatol 2004; 31: 508–513.

    PubMed  Google Scholar 

  27. Aranda P, et al., for the Sildenafil Study Group. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study. Am J Hypertens 2004; 17: 139–145.

    Article  CAS  Google Scholar 

  28. Bai WJ et al. Diagnostic approaches of neurogenic erectile dysfunction. Zhonghua Nan Ke Xue 2002; 8: 403–410.

    Google Scholar 

  29. Savoca G et al. Long-term results with Nesbit's as treatment of Peyronie's disease. Int J Impot Res 2000; 12: 289–293.

    Article  CAS  Google Scholar 

  30. Hsu G-L et al. Penile venous anatomy: application to surgery for erectile disturbance. Asian J Androl 2002; 4: 61–66.

    PubMed  Google Scholar 

  31. Noldus J et al. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur Urol 2002; 42: 118–124.

    Article  Google Scholar 

  32. Zargooshi J . Penile fracture in Kermanshah, Iran: the long-term results of surgical treatment. BJU Int 2002; 89: 890–894.

    Article  Google Scholar 

  33. Martínez-Jabaloyas J et al. Prognostic factors for response to sildenafil in patients with erectile dysfunction. Eur Urol 2001; 40: 641–647.

    Article  Google Scholar 

  34. Guirao Sánchez L, García-Giralda Ruiz L, Sandoval Martínez C, Mocciaro Loveccio A . Erectile dysfunction in primary care as possible marker of health status: associated factors and response to sildenafil. Aten Primaria 2002; 30: 290–296.

    Article  Google Scholar 

  35. Atiemo HO, Szostak MJ, Sklar GN . Salvage of sildenafil failures referred from primary care physicians. J Urol 2003; 170: 2356–2358.

    Article  Google Scholar 

  36. Jiann B-P, Yu C-C, Su C-C, Huang J-K . Rechallenge prior sildenafil nonreponders. Int J Impot Res 2004; 16: 64–68.

    Article  CAS  Google Scholar 

  37. Martínez Jabaloyas JM et al. Efficacy and safety of sildenafil in patients with erectile dysfunction and hypertension. Med Clin 2002; 119: 281–285.

    Article  Google Scholar 

  38. Mondaini N et al. Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. Int J Impot Res 2003; 15: 225–228.

    Article  CAS  Google Scholar 

  39. Cherdshewasart W, Nimsakul N . Clinical trial of Butea superba, an alternative herbal treatment for erectile dysfunction. Asian J Androl 2003; 5: 243–246.

    CAS  PubMed  Google Scholar 

  40. Sadeghi-Nejad H, Sherman N, Lue J . Comparison of finasteride and alpha-blockers as independent risk factors for erectile dysfunction. Int J Clin Pract 2003; 57: 484–487.

    CAS  PubMed  Google Scholar 

  41. Jaffe JS et al. Use of intraurethral alprostadil in patients not responding to sildenafil citrate. Urology 2004; 63: 951–954.

    Article  Google Scholar 

  42. Saltzman EA, Guay AT, Jacobson J . Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004; 172: 255–258.

    Article  Google Scholar 

  43. Barqawi A, Gamito E, O’Donnell C, Crawford ED . Herbal and vitamin supplement use in a prostate cancer screening population. Urology 2004; 63: 288–292.

    Article  Google Scholar 

  44. Raina R et al. Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate. Urology 2003; 62: 1103–1108.

    Article  Google Scholar 

  45. Raina R et al. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003; 62: 110–115.

    Article  Google Scholar 

  46. Raina R et al. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy. Urology 2004; 63: 532–538.

    Article  Google Scholar 

  47. Raina R et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 2004; 63: 960–966.

    Article  Google Scholar 

  48. Ogura K et al. Role of sildenafil citrate in treatment of erectile dysfunction after radical retropubic prostatectomy. Int J Urol 2004; 11: 159–163.

    Article  CAS  Google Scholar 

  49. Liu F et al. Sildenafil citrate for erectile dysfunction in make kidney transplant recipient. Zhonghua Nan Ke Xue 2004; 10: 455–457.

    PubMed  Google Scholar 

  50. Raina R et al. Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 2003; 15: 318–322.

    Article  CAS  Google Scholar 

  51. Guest JL, Das Gupta R . Health-related quality of life in a UK-based population of men with erectile dysfunction. Pharmacoeconomics 2002; 20: 109–117.

    Article  Google Scholar 

  52. Day D, Ambegaonkar A, Harriot K, McDaniel A . A new tool for predicting erectile dysfunction. Adv Ther 2001; 18: 131–139.

    Article  CAS  Google Scholar 

  53. Mondaini N et al. Penile length is normal in most men seeking penile lengthening procedures. Int J Impot Res 2002; 14: 283–286.

    Article  CAS  Google Scholar 

  54. Kassouf W, Carrier S . A comparison of the International Index of Erectile Function and erectile dysfunction studies. BJU Int 2003; 91: 667–669.

    Article  CAS  Google Scholar 

  55. Elliott SP et al. Obstructive lower urinary tract symptoms correlate with erectile dysfunction. Urology 2004; 63: 1148–1152.

    Article  Google Scholar 

  56. Fung MM, Bettencourt R, Barrett-Connor E . Heart disease risk factors predict erectile dysyears later: The Rancho Bernardo Study. J Am Coll Cardiol 2004; 43: 1405–1411.

    Article  Google Scholar 

  57. Mulhall JP et al. Subjective and objective analysis of the prevalence of Peryonie's disease in a population of men presenting for prostate cancer screening. J Urol 2004; 171: 2350–2353.

    Article  Google Scholar 

  58. Lim TO et al. Cross-cultural adaptation and validation of the English version of the International Index of Erectile Function (IIEF) for use in Malaysia. Int J Impot Res 2003; 15: 329–336.

    Article  CAS  Google Scholar 

  59. Vroege JA . Letter to the Editor. The Sexual Health Inventory for Men (IIEF-5). Int J Impot Res 1999; 11: 177.

    Article  CAS  Google Scholar 

  60. Vroege JA . Letter to the Editor. The Sexual Health Inventory for men (IIEF-5): reply to Cappelleri and Rosen. Int J Impot Res 2000; 12: 297–298.

    Article  CAS  Google Scholar 

  61. Cappelleri JC, Rosen RC . Correspondence (reply). The Sexual Health Inventory for Men (IIEF-5). Int J Impot Res 1999; 11: 353–354.

    Article  CAS  Google Scholar 

  62. Rosen RC, Cappelleri JC . Correspondence (reply). The Sexual Health Inventory for Men (IIEF-5): Reply to Vroege. Int J Impot Res 2001; 12: 342–343.

    Article  Google Scholar 

  63. Cappelleri JC, Rosen RC . A comparison of the International Index of Erectile Function and erectile dysfunction studies: reply to Kassouf and Carrie. BJU Int 2003; 92: 654.

    Article  CAS  Google Scholar 

  64. Tosti A et al. Evaluation of sexual function with an International Index of Erectile Function in subjects taking finasteride for androgenetic alopecia. Arch Dermatol 2004; 14: 857–858.

    Google Scholar 

  65. Cappelleri JC et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346–351.

    Article  CAS  Google Scholar 

  66. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC . Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function. Urology 2000; 56: 477–481.

    Article  CAS  Google Scholar 

  67. Lehmann K, Eichlisberger R, Gasser TC . Lack of diagnostic to prove erectile dysfunction: consequences for reimbursement? J Urol 2000; 163: 91–94.

    Article  CAS  Google Scholar 

  68. Kantor J, Bilker WB, Glasser DB, Margolis DJ . Prevalence of erectile dysfunction and active depression: an analytic cross-sectional study of general medical patients. Am J Epidemiol 2002; 156: 1035–1042.

    Article  Google Scholar 

  69. Rosen RC et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004; 20: 607–617.

    Article  Google Scholar 

  70. Feldman HA et al. Impotence and its medical and psychosocial correlations: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    Article  CAS  Google Scholar 

  71. Derby CA et al. Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impot Res 2000; 12: 197–204.

    Article  CAS  Google Scholar 

  72. Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS . Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension or both. Urology 2004; 64: 1196–1201.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pfizer Inc., Global Research and Development, Groton, CT, USA

    J C Cappelleri

  2. University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ, USA

    R C Rosen

Authors
  1. J C Cappelleri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R C Rosen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J C Cappelleri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cappelleri, J., Rosen, R. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 17, 307–319 (2005). https://doi.org/10.1038/sj.ijir.3901327

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901327

Keywords

This article is cited by

Search

Advanced search

Quick links